Erasca, Inc.

ERAS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001761918

SEC filings (opens in a new tab)

No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Erasca, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ERAS: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	112	109	−3
Shares	74.3M	71.3M	−3.05M (−4.1%)
Value	$205.2M	$140.4M	−$64.8M (−31.6%)

New holders (9)

Institutions that held Erasca, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ERAS in Q3 2023
Institution	Shares	Value	% of portfolio
Sanders Morris Harris LLC	425,297	$816.6K	0.17%
HRT Financial LP	149,770	$295.0K	0.00%
Denali Advisors LLC	112,600	$221.8K	0.08%
Pale Fire Capital SE	42,101	$82.9K	0.01%
SG Americas Securities, LLC	38,521	$76.0K	0.00%
AQR Capital Management LLC	13,058	$25.7K	0.00%
Creative Planning	11,609	$22.9K	0.00%
Victory Capital Management Inc	10,125	$19.9K	0.00%
Capital Advisors, Ltd. LLC	316	$1.00K	0.00%

Sold out (12)

Institutions that held Erasca, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ERAS in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Jacobs Levy Equity Management, Inc	136,201	$375.9K
Walleye Capital LLC	104,137	$287.4K
State of Wisconsin Investment Board	43,053	$118.8K
Ameriprise Financial Inc	32,507	$89.7K
Oppenheimer & Co Inc	26,287	$72.6K
Erste Asset Management GmbH	25,000	$66.8K
Laurion Capital Management LP	23,100	$63.8K
Schonfeld Strategic Advisors LLC	20,900	$57.7K
Nebula Research & Development LLC	17,198	$47.5K
Centiva Capital, LP	12,056	$33.3K
Martingale Asset Management L P	11,032	$30.4K
The PNC Financial Services Group, Inc.	1,818	$5.02K